ArticleTherapeutic advances in musculoskeletal disease2019

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study.

Louis Bessette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.